Good morning :)
Switch to
Place Order

Balaxi Pharmaceuticals Ltd

BALAXI
Health CareHealth Care Equipment & Supplies
SmallcapWith a market cap of ₹576 cr, stock is ranked 1,278
High RiskStock is 3.08x as volatile as Nifty
556.903.20% (-18.40)
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareHealth Care Equipment & Supplies
SmallcapWith a market cap of ₹576 cr, stock is ranked 1,278
High RiskStock is 3.08x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
12.105.100.09%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.354.320.90%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

The company is engaged in wholesale trading of pharmaceuticals products, food products and builders’ hardware products. The Company offers a range of food and biscuit products under the brand name YAP.

Investor PresentationView older 

Nov 5, 2022

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+14.49+46.22+233.56+284.36+1.98+6.09+38.13+47.66
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Related Party Transaction 
Announced OnNov 17, 2022

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about related party transaction for the period ended September 2022 | Download

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about related party transaction for the period ended September 2022 | Download

Transcript of Analysts/Institutional Investor Meet/Con. Call 
Announced OnNov 15, 2022

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

Cash Dividend 
Ex. DateJul 1, 2022

Final • Div/Share: ₹ 0.5

See all events